# Endonovo Therapeutics, Inc. (OTC: ENDV), Woodland Hills, CA – FDA Inspections

Source: https://www.keypedia.com/companies/endonovo-therapeutics-inc/819d1466-398f-4ac9-87a8-052819520724

> Inspection records and compliance data for Endonovo Therapeutics, Inc. in Woodland Hills, California. 3 FDA inspections on record, 1 Form 483, last inspected October 31, 2025. Publicly traded as OTC: ENDV.

---

## Details

- Name: Endonovo Therapeutics, Inc.
- FEI Number: 3014308816
- Address Line 1: 6320 Canoga Ave Fl 15
- City: Woodland Hills
- State: California
- Zip Code: 91367
- Country Name: United States
- Address: 6320 Canoga Ave Fl 15, Woodland Hills, California 91367, United States
- Country: United States

## Stock

- Stock ticker: ENDV
- Exchange: OTC
- Price as of: November 13, 2026

## Related Documents

- [483 - Endonovo Therapeutics, Inc. - 2025-10-31](https://www.keypedia.com/records/483/endonovo-therapeutics-inc/b0504c60-1da2-4132-b1e4-56ce0804e80c) — source: FDA, date: October 31, 2025
- FDA Inspection 1289500 - Endonovo Therapeutics, Inc. - 2025-10-31 — classification: Voluntary Action Indicated (VAI), source: FDA, date: October 31, 2025
- [FDA Inspection 1289500 - Endonovo Therapeutics, Inc. - 2025-10-31](https://www.keypedia.com/records/fda_inspections/endonovo-therapeutics-inc/d4a5098f-5a68-453f-9404-7e0705957b33) — classification: No Action Indicated (NAI), source: FDA, date: October 31, 2025
- FDA Inspection 1289500 - Endonovo Therapeutics, Inc. - 2025-10-31 — classification: No Action Indicated (NAI), source: FDA, date: October 31, 2025
- FDA Inspection 1289500 - Endonovo Therapeutics, Inc. - 2025-10-31 — classification: Voluntary Action Indicated (VAI), source: FDA, date: October 31, 2025
- FDA Inspection 1181508 - Endonovo Therapeutics, Inc. - 2022-10-13 — classification: No Action Indicated (NAI), source: FDA, date: October 13, 2022
- FDA Inspection 1181508 - Endonovo Therapeutics, Inc. - 2022-10-13 — classification: No Action Indicated (NAI), source: FDA, date: October 13, 2022
- FDA Inspection 1093798 - Endonovo Therapeutics, Inc. - 2019-05-14 — classification: No Action Indicated (NAI), source: FDA, date: May 14, 2019
- FDA Inspection 1093798 - Endonovo Therapeutics, Inc. - 2019-05-14 — classification: No Action Indicated (NAI), source: FDA, date: May 14, 2019

## Related Companies

- [Epitope Diagnostics, Inc.](https://www.keypedia.com/companies/epitope-diagnostics-inc/d5642a4a-6034-4f05-a7e7-3a2b3ea5116c)
- [Syntech International, Inc](https://www.keypedia.com/companies/syntech-international-inc/f83b30aa-4538-43dd-834e-ef92c43329ca)
- [OrthoSource Inc](https://www.keypedia.com/companies/orthosource-inc/266fbd9f-f725-44bd-98ef-4b90d9778031)
- [Accriva Diagnostics, Inc.](https://www.keypedia.com/companies/accriva-diagnostics-inc/64baca98-c5ea-45c9-adcf-827cc30747ab)
- [Trinity Orthopedics, LLC](https://www.keypedia.com/companies/trinity-orthopedics-llc/2b4c1565-1b4a-468e-805c-3aa4d6f2da32)
- [Kentec Medical, Inc](https://www.keypedia.com/companies/kentec-medical-inc/84a3c6bd-182a-4acd-bf51-a7482ed87bd7)
- [OcuMetrics, Inc.](https://www.keypedia.com/companies/ocumetrics-inc/a293f272-b12c-428f-b92c-9d4422e54155)
- [Prime Herbs Corporation](https://www.keypedia.com/companies/prime-herbs-corporation/41b22daf-5fa0-4b99-b964-651cd81ea344)
- [Pro-Tech Design & Mfg. Inc.](https://www.keypedia.com/companies/pro-tech-design-mfg-inc/48cb121e-511f-4b89-914b-507ccc03ef34)
- [Myron L Company](https://www.keypedia.com/companies/myron-l-company/5ebef52d-5c22-42e2-a337-a79e56fc5b89)

## Related Officers

- [investigator](https://www.keypedia.com/people/sarah-a-hassas/4f142d54-fc28-4bd5-82ad-7e6fa443688c)
